Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT after AutoHSCT in MS
NCT04203017Phase 1Terminated
- Sponsor
- First Saint Petersburg State Medical University
- Start
- Jun 2019
- Primary completion
- Nov 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Fecal Microbiota Transplantation Capsule in multiple sclerosis (MS), sponsored by First Saint Petersburg State Medical University. Primary endpoint: Effectiveness of autoHSCT in combination with FMT at 365 days. Started Jun 2019; status: terminated.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04203017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04203017.